Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Taisho Pharmaceutical Holdings Co Ltd (TAISF)
OTHER OTC:TAISF
Holding TAISF?
Track your performance easily
TAISF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$38.00 - $60.00
Previous Close$59
Volume100.00
Average Volume (3M)100.00
Market Cap
$4.64B
Enterprise Value$3.00B
Total Cash (Recent Filing)$272.59B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)83.2
Beta0.04
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.23%
Share Statistics
EPS (TTM)0.71
Shares Outstanding81,985,653
10 Day Avg. Volume0
30 Day Avg. Volume100
Standard Deviation0.10
R-Squared0.02
Alpha-0.00757
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.01
Enterprise Value/Gross Profit0.02
Enterprise Value/Ebitda0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TAISF FAQ
What was Taisho Pharmaceutical Holdings Co Ltd’s price range in the past 12 months?
Taisho Pharmaceutical Holdings Co Ltd lowest stock price was $38.00 and its highest was $60.00 in the past 12 months.
What is Taisho Pharmaceutical Holdings Co Ltd’s market cap?
Currently, no data Available
When is Taisho Pharmaceutical Holdings Co Ltd’s upcoming earnings report date?
Taisho Pharmaceutical Holdings Co Ltd’s upcoming earnings report date is May 13, 2024 which is 131 days ago.
How were Taisho Pharmaceutical Holdings Co Ltd’s earnings last quarter?
Taisho Pharmaceutical Holdings Co Ltd released its earnings results on Feb 13, 2024. The company reported $0.237 earnings per share for the quarter, beating the consensus estimate of N/A by $0.237.
Is Taisho Pharmaceutical Holdings Co Ltd overvalued?
According to Wall Street analysts Taisho Pharmaceutical Holdings Co Ltd’s price is currently Overvalued.
Does Taisho Pharmaceutical Holdings Co Ltd pay dividends?
Taisho Pharmaceutical Holdings Co Ltd does not currently pay dividends.
What is Taisho Pharmaceutical Holdings Co Ltd’s EPS estimate?
Taisho Pharmaceutical Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Taisho Pharmaceutical Holdings Co Ltd have?
Taisho Pharmaceutical Holdings Co Ltd has 85,139,656 shares outstanding.
What happened to Taisho Pharmaceutical Holdings Co Ltd’s price movement after its last earnings report?
Taisho Pharmaceutical Holdings Co Ltd reported an EPS of $0.237 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Taisho Pharmaceutical Holdings Co Ltd?
Currently, no hedge funds are holding shares in TAISF
---
Taisho Pharmaceutical Holdings Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.75%
12-Months-Change
Fundamentals
Return on Equity
0.98%
Trailing 12-Months
Asset Growth
-0.61%
Trailing 12-Months
Company Description
Taisho Pharmaceutical Holdings Co Ltd
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies. The Prescription Pharmaceutical segment handles R&D, manufacturing, and sale of ethical drugs. It also provides the manufacture and sale of prescription pharmaceuticals; and businesses incidental or related thereto. The company was founded on October 3, 2011 and is headquartered in Tokyo, Japan.
---
Technical Analysis
---